Mathias Uhlén,Fredrik Pontén,Karin Jirström,Donal J. Brennan
申请号：
US13201740
公开号：
US20120058202A1
申请日:
2010.02.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
There is provided a method for determining whether a mammalian subject having an ovarian cancer belongs to a first or a second group, wherein the prognosis of subjects of the first group is better than the prognosis of subjects of the second group, comprising the steps of: a) evaluating an amount of RBM3 protein in at least part of a sample earlier obtained from the subject and determining a sample value corresponding to the evaluated amount b) comparing said sample value with a predetermined refer-ence value and if said sample value is higher than said ref-erence value, c1) concluding that the subject belongs to the first group and if said sample value is lower than or equal to said reference value, c2) concluding that the sub-ject belongs to the second group. Related peptides, affinity ligands, uses and further methods are also provided.
